APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $26,005,000 | +23.6% | 411,471 | -16.1% | 3.07% | +53.4% |
Q1 2021 | $21,046,000 | -25.0% | 490,471 | 0.0% | 2.00% | -19.2% |
Q4 2020 | $28,055,000 | +85.4% | 490,471 | -2.2% | 2.48% | +7.7% |
Q3 2020 | $15,133,000 | -7.6% | 501,584 | 0.0% | 2.30% | -83.1% |
Q2 2020 | $16,382,000 | +21.9% | 501,584 | 0.0% | 13.62% | +19.0% |
Q1 2020 | $13,437,000 | -56.1% | 501,584 | -49.8% | 11.45% | -12.8% |
Q4 2019 | $30,620,000 | +27.1% | 1,000,000 | 0.0% | 13.13% | +14.9% |
Q3 2019 | $24,090,000 | -4.9% | 1,000,000 | 0.0% | 11.43% | +1.6% |
Q2 2019 | $25,340,000 | -14.8% | 1,000,000 | -34.5% | 11.24% | -53.3% |
Q1 2019 | $29,759,000 | +26.0% | 1,526,122 | -14.7% | 24.10% | -61.1% |
Q4 2018 | $23,611,000 | – | 1,790,102 | – | 62.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |